Donald Trump's tariff move impacts Indian pharma stocks. Companies like Sun Phar...
With the US accounting for nearly 35% of India’s overall pharma shipments of ove...
Stock market recommendations: Mirae Asset Sharekhan's Somil Mehta recommends buy...
Pharmaceutical stocks, particularly Indian firms, plummeted following President ...
India Ratings and Research (Ind-Ra) anticipates minimal credit profile impact on...
US President Donald Trump has said his administration will impose 100 per cent i...
US President Trump announced a 100% tariff on imported branded and patented phar...
Indian firm Natco Pharma is set to acquire substantial stakes in South African p...
Semaglutide patent expiries in India, Canada, and Brazil are poised to unlock ov...
Industry leaders in pharma and MedTech are urging the government to establish a ...
Asian drug stocks faced a downturn. This followed US President Trump's tariff th...
Dalal Street plunged this week, with over 440 BSE 500 stocks in red, following U...
India's top-10 companies saw their combined market valuation shrink by nearly Rs...
Stock market recommendations: Nifty and Bank Nifty experienced significant decli...
An alert was issued against specific batches of Coldrif from Sresan Pharmaceutic...
India Inc. saw revenue grow by up to 6% in the July-September quarter, driven by...
